Literature DB >> 24238152

Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis.

I Pagnini1, G Simonini, T Giani, E Marrani, D Moretti, G Vannucci, L Cantarini, R Cimaz.   

Abstract

We report the successful use of sodium thiosulfate in a patient with juvenile dermatomyositis complicated by ulcerative skin disease and progressive calcinosis. This therapy may have a role in improving calcinosis, even if more studies are necessary to determine the safety and efficacy of this treatment in juvenile dermatomyositis-related calcinosis.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24238152

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

Review 3.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

Review 4.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

5.  Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO2 laser treatment.

Authors:  Misty G Eleryan; Olabola Awosika; Sophia Akhiyat; Azam Qureshi; Monica Rengifo-Pardo; Rodolfo Curiel; Lisa G Rider; Alison Ehrlich
Journal:  Clin Exp Rheumatol       Date:  2019-11-18       Impact factor: 4.473

Review 6.  Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.

Authors:  Ilaria Pagnini; Antonio Vitale; Carlo Selmi; Rolando Cimaz; Luca Cantarini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 10.817

Review 7.  Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management.

Authors:  Alison M Boyce; Alisa E Lee; Kelly L Roszko; Rachel I Gafni
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-08       Impact factor: 5.555

Review 8.  Local, non-systemic, and minimally invasive therapies for calcinosis cutis: a systematic review.

Authors:  Joanna Nowaczyk; Michał Zawistowski; Piotr Fiedor
Journal:  Arch Dermatol Res       Date:  2021-06-24       Impact factor: 3.033
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.